| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |